Ionis Pharmaceuticals(IONS) - 2023 Q4 - Earnings Call Presentation

February 21, 2024 On Today's Earnings Call Brett Monia, Ph.D. Chief Executive Officer Beth Hougen Chief Financial Officer Eugene Schneider, M.D. Chief Clinical Development Officer IONIS 3 In this presentation, unless the context requires otherwise, "Ionis," "Company," "we," "our," and "us" refers to Ionis Pharmaceuticals and its subsidiaries. Introduction Brett Monia, Ph.D. Chief Executive Officer Key Achievements in the Last 12 Months Bepirovirsen (HBV) IONIS-FB-LRx (IgAN) FDA Approvals1 Positive Phase 3 R ...